| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |